Skip to content
healthcare.dev

Anthrasil

NDC 60492-0249, Anthrax immune globulin (human), liquid, from Emergent BioSolutions Canada Inc..

Product NDC
60492-0249
Status
Listed
Labeler
Emergent BioSolutions Canada Inc.
Dosage form
LIQUID
Route
INTRAVENOUS
Product type
PLASMA DERIVATIVE
Marketing category
BLA
Application
BLA125562
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60492-0249 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ANTHRAX IMMUNE GLOBULIN HUMAN60 [iU]/35mL
Package NDCNDC-11Package
60492-0249-2604920249027 VIAL in 1 CARTON (60492-0249-2) / 35 mL in 1 VIAL (60492-0249-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 60492-0249 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60492-0249 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60492-0249. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.